Drug Safety System Will Be Improved By Medicare Rx, HHS Secretary Tells PhRMA
This article was originally published in The Pink Sheet Daily
Executive Summary
The Part D benefit will allow HHS to gather useful postmarketing data to help improve the regulation of drug safety, Leavitt says. The HHS Secretary dowplays the need for legislative changes at FDA.